Exploring the family experience of children aged 2 –4 years receiving daily vosoritide injections: A qualitative study

Vosoritide is administered as a daily subcutaneous injection in children with achondroplasia. In clinical trials, families of children aged 2 –4 years reported difficulty with drug administration due to child fear, pain, and distress. Study aims were to gain a better understanding of the current vosoritide administration experience in this cohort and to investigate whether topical anaesthesia and ice application prior to injections imp roved the child and family experience.
Source: Journal of Pediatric Nursing - Category: Nursing Authors: Source Type: research